World Lung Cancer Day 2026 highlights need for early detection and equitable access to care

As the world observes World Lung Cancer Day on August 1, 2026, this year’s theme, ‘Together Through Lung Cancer’, focuses on the role of community support and equitable access to lung cancer screening.

According to the WHO Global Status Report on Cancer 2026, nearly 20.6 million new cancer cases and around 10 million cancer-related deaths are recorded each year, making cancer the second leading cause of death globally after heart disease. The report estimates that new cancer cases will reach around 35 million by 2050. Lung cancer remains one of the leading causes of cancer-related deaths worldwide and is among the most commonly diagnosed cancers in both men and women, accounting for more cancer-related deaths than colorectal, breast or prostate cancer.

The report states that surgery remains one of the primary treatment options for people diagnosed with early-stage lung cancer. However, access to lung cancer surgery remains inconsistent, while screening for lung and colorectal cancers has the lowest level of implementation among cancers globally. Screening programmes largely target high-risk populations, primarily in higher-income settings, through low-dose CT scans. Many lung cancer cases continue to be diagnosed at an advanced stage, despite earlier diagnosis being associated with improved survival and lower treatment costs. The report highlights the need for diagnostic pathways and faster referrals to improve patient outcomes.

The report also notes that lung cancer prevention requires addressing multiple risk factors, including fine particulate air pollution, in addition to smoking.

Sharing his views on World Lung Cancer Day, Gaurav Verma, Chief Business Officer at PharmEasy (API Holdings), said: “World Lung Cancer Day is a call to action — a reminder that awareness, early detection, and timely access to care can make all the difference in the fight against cancer. Recognising risk factors and symptoms early can encourage people to seek medical advice sooner, but a cancer diagnosis brings challenges that go far beyond the clinical. For patients and their families, the treatment journey is often long and difficult, and affordable access to essential medicines becomes a critical part of that fight. At PharmEasy, we are committed to easing at least one part of that burden — by simplifying access to essential cancer medicines and making them more affordable, with savings of up to 45 percent on select medicines. As we continue to leverage technology to expand healthcare access, our commitment to support patients and their families through every step of their treatment journey remains unwavering.”

Recently, Union Minister for Health & Family Welfare Jagat Prakash Nadda released the ‘Lung Cancer Treatment and Palliation: Evidence-Based Guidelines’, where he highlighted early detection as one of the key challenges in lung cancer management and emphasised the need to strengthen screening strategies, particularly among high-risk populations.

This year’s observance calls for greater focus on equitable healthcare, closing gaps in early screening and strengthening community support for people affected by lung cancer.